(Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

Jurors in Chicago's Cook County Circuit Court sided with drug manufacturers, but more trials are planned in Illinois, California and Pennsylvania. Drugmakers have appealed a judge's refusal to toss 10 ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...

Products we regularly use or consume are sometimes recalled over safety concerns — like having ingredients that can make us sick or components that can hurt us. Time highlighted a Public Interest ...

CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.

Filing a Zantac claim is a crucial step toward securing justice and financial relief for those affected. By gathering essential documents, such as medical records, prescription proof, and evidence of ...

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had informed ...